<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> Ay Health Medical Services Company</title>
	<atom:link href="https://ayhcare.com/feed/" rel="self" type="application/rss+xml" />
	<link>https://ayhcare.com</link>
	<description></description>
	<lastBuildDate>Sun, 13 Aug 2023 08:59:06 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.7.2</generator>

<image>
	<url>https://ayhcare.com/wp-content/uploads/2021/08/cropped-ayhealth-logo-32x32.png</url>
	<title> Ay Health Medical Services Company</title>
	<link>https://ayhcare.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">203056789</site>	<item>
		<title>Advanced wards in Gastrinology</title>
		<link>https://ayhcare.com/advanced-wards-in-gastrinology/</link>
		
		<dc:creator><![CDATA[Adminayh]]></dc:creator>
		<pubDate>Sun, 13 Aug 2023 08:53:42 +0000</pubDate>
				<guid isPermaLink="false">https://ayhcare.com/?p=3523</guid>

					<description><![CDATA[<p>Describe one of the most advanced wards in Gastrinology with Dr Shahram Agah Dr Shahram Agah: Gastroenterology and liver specialist from Tehran University of Medical Sciences Fellowship in endosonography and endoscopy therapeutics from the German Elliptical University</p>
<p>The post <a rel="nofollow" href="https://ayhcare.com/advanced-wards-in-gastrinology/">Advanced wards in Gastrinology</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p dir="ltr" style="text-align: left;">Describe one of the most advanced wards in Gastrinology with Dr Shahram Agah</p>
<p dir="ltr">Dr Shahram Agah:</p>
<ul>
<li dir="ltr" style="text-align: left;">Gastroenterology and liver specialist from Tehran University of Medical Sciences</li>
<li dir="ltr" style="text-align: left;">Fellowship in endosonography and endoscopy therapeutics from the German Elliptical University</li>
</ul>
<div id="98605798978"><script type="text/JavaScript" src="https://www.aparat.com/embed/QaVCz?data[rnddiv]=98605798978&#038;data[responsive]=yes"></script></div>
<p>The post <a rel="nofollow" href="https://ayhcare.com/advanced-wards-in-gastrinology/">Advanced wards in Gastrinology</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">3523</post-id>	</item>
		<item>
		<title>About Lung cancer</title>
		<link>https://ayhcare.com/new-discovery/</link>
		
		<dc:creator><![CDATA[Adminayh]]></dc:creator>
		<pubDate>Sun, 30 Jul 2023 10:21:09 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[lumkras]]></category>
		<category><![CDATA[Lung]]></category>
		<guid isPermaLink="false">https://ayhcare.com/?p=3270</guid>

					<description><![CDATA[<p>New discovery of scientists in McGill University Health Centre about lung cancer in change the way we treat non-small cell lung cancer.</p>
<p>The post <a rel="nofollow" href="https://ayhcare.com/new-discovery/">About Lung cancer</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></description>
										<content:encoded><![CDATA[	<div id="text-2778964041" class="text">
		
<h3 dir="ltr" style="text-align: center;">New discovery of scientists about lung cancer</h3>
<p><img fetchpriority="high" decoding="async" class="wp-image-3274 alignnone" src="https://ayhcare.com/wp-content/uploads/2022/09/1-19397-300x167.jpeg" alt="" width="430" height="239" srcset="https://ayhcare.com/wp-content/uploads/2022/09/1-19397-300x167.jpeg 300w, https://ayhcare.com/wp-content/uploads/2022/09/1-19397.jpeg 759w" sizes="(max-width: 430px) 100vw, 430px" /></p>
<h4 dir="ltr" style="text-align: left;"><span style="font-size: 80%;">Together, the McGill University Health Centre (MUHC), the Centre hospitalier de l’Université de Montréal (CHUM) and St. Mary’s Hospital Center (SMHC) have contributed to an international clinical trial that will change the way we treat non-small cell lung cancer (NSCLC)—the most common form of lung cancer. In this trial, an immunotherapy drug called pembrolizumab (KEYTRUDA®), used in conjunction with neoadjuvant chemotherapy (i.e., given before surgery) and then again after surgery, has been shown to slow cancer progression and recurrence and to reduce the presence of residual tumours in patients with early-stage operable NSCLC. In the experimental group, three out of five patients remained stable for two years (without cancer progression or recurrence), compared with two out of five in the control group, an improvement of around 50 per cent.</span></h4>
<h4 dir="ltr"><span style="font-size: 80%;">The interim analysis of this randomized, double-blind, Phase III clinical trial was recently presented at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting in Chicago and published in The New England Journal of Medicine.</span></h4>
		
<style>
#text-2778964041 {
  text-align: center;
}
</style>
	</div>
	
<p>The post <a rel="nofollow" href="https://ayhcare.com/new-discovery/">About Lung cancer</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">3270</post-id>	</item>
		<item>
		<title>Cervical Cancer</title>
		<link>https://ayhcare.com/cervical-cancer/</link>
		
		<dc:creator><![CDATA[Adminayh]]></dc:creator>
		<pubDate>Sat, 29 Jul 2023 05:29:07 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cervical]]></category>
		<category><![CDATA[doctor]]></category>
		<category><![CDATA[surgery]]></category>
		<guid isPermaLink="false">https://ayhcare.com/?p=3352</guid>

					<description><![CDATA[<p>Cervical cancer is the growth of abnormal cells in the lining of the cervix. The most common cervical cancer is squamous cell carcinoma, accounting for 70% of cases. Adenocarcinoma is less common (about 25% of cases) and more difficult to diagnose because it starts higher in the cervix. It is estimated that more than 900 people were [...]</p>
<p>The post <a rel="nofollow" href="https://ayhcare.com/cervical-cancer/">Cervical Cancer</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><img decoding="async" class=" wp-image-3449 aligncenter" style="color: #555555; font-size: 14.4px;" src="https://ayhcare.com/wp-content/uploads/2023/05/2022-12-21-CERVICALCANCER-Index_1170x780-300x169.jpg" alt="" width="401" height="226" srcset="https://ayhcare.com/wp-content/uploads/2023/05/2022-12-21-CERVICALCANCER-Index_1170x780-300x169.jpg 300w, https://ayhcare.com/wp-content/uploads/2023/05/2022-12-21-CERVICALCANCER-Index_1170x780-1024x576.jpg 1024w, https://ayhcare.com/wp-content/uploads/2023/05/2022-12-21-CERVICALCANCER-Index_1170x780-768x432.jpg 768w, https://ayhcare.com/wp-content/uploads/2023/05/2022-12-21-CERVICALCANCER-Index_1170x780.jpg 1280w" sizes="(max-width: 401px) 100vw, 401px" /></p>
<h4 dir="ltr" style="text-align: left;"><span style="font-size: 100%;">Cervical cancer is the growth of abnorm</span><span style="font-size: 100%;">al cells in the lining of the cervix. The most common cervical cancer is squamous cell carcinoma, accounting for 70% of cases. Adenocarcinoma is less </span><span style="font-size: 100%;">common (about 25% of cases) and more difficult to diagnose because it starts higher in the cervix.</span></h4>
<h4 dir="ltr">It is estimated that more than 900 people were diagnosed with cervical cancer in 2022. The average age at diagnosis is 49 years old.</h4>
<h4 dir="ltr" style="text-align: left;">Precancerous changes in cervical cells rarely cause symptoms. The only way to know if there are abnormal cells that may develop into cancer is to have a cervical screening test. If early cell changes develop into cervical cancer, the most common signs include:</h4>
<ul dir="ltr" style="text-align: left;">
<li>
<h4>vaginal bleeding between periods</h4>
</li>
<li>
<h4>menstrual bleeding that is longer or heavier than usual</h4>
</li>
<li>
<h4>pain during intercourse</h4>
</li>
<li>
<h4>bleeding after intercourse</h4>
</li>
<li>
<h4>pelvic pain</h4>
</li>
<li>
<h4>a change in your vaginal discharge such as more discharge or it may have a strong or unusual color or smell</h4>
</li>
<li>
<h4>vaginal bleeding after menopause.</h4>
</li>
</ul>
<h4 dir="ltr" style="text-align: left;"> </h4>
<p>The post <a rel="nofollow" href="https://ayhcare.com/cervical-cancer/">Cervical Cancer</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">3352</post-id>	</item>
		<item>
		<title>Outcome of pediatric renal transplantation</title>
		<link>https://ayhcare.com/outcome-of-pediatric-renal-transplantation/</link>
		
		<dc:creator><![CDATA[Adminayh]]></dc:creator>
		<pubDate>Tue, 25 Jul 2023 15:14:35 +0000</pubDate>
				<category><![CDATA[compliance]]></category>
		<category><![CDATA[intervals]]></category>
		<category><![CDATA[Iran]]></category>
		<category><![CDATA[Labfi Nejad Hospital]]></category>
		<category><![CDATA[modus]]></category>
		<category><![CDATA[Outcome]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[renal]]></category>
		<category><![CDATA[Tehran]]></category>
		<category><![CDATA[time]]></category>
		<guid isPermaLink="false">https://ayhcare.com/?p=3205</guid>

					<description><![CDATA[<p>Outcome of pediatric renal transplantation  The most common causes of end-stage renal disease (ESRD) in children are congenital, cystic, and hereditary diseases, which combined account for 38% of incident cases. The most common disorders in this category are congenital obstructive uropathies (9.5%) and renal hypoplasia/dysplasia (10%). Primary glomerular disease is the second-most common etiology accounting [...]</p>
<p>The post <a rel="nofollow" href="https://ayhcare.com/outcome-of-pediatric-renal-transplantation/">Outcome of pediatric renal transplantation</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></description>
										<content:encoded><![CDATA[<h1 style="text-align: center;"><strong>Outcome of pediatric renal transplantation </strong></h1>
<p style="text-align: center;"><img decoding="async" class="wp-image-3208 aligncenter" src="https://ayhcare.com/wp-content/uploads/2022/07/girl-in-hospital-bed-300x100.jpg" alt="" width="690" height="230" srcset="https://ayhcare.com/wp-content/uploads/2022/07/girl-in-hospital-bed-300x100.jpg 300w, https://ayhcare.com/wp-content/uploads/2022/07/girl-in-hospital-bed-768x256.jpg 768w, https://ayhcare.com/wp-content/uploads/2022/07/girl-in-hospital-bed.jpg 900w" sizes="(max-width: 690px) 100vw, 690px" /></p>
<h4 dir="ltr" style="text-align: left;">The most common causes of end-stage renal disease (ESRD) in children are congenital, cystic, and hereditary diseases, which combined account for 38% of incident cases. The most common disorders in this category are congenital obstructive uropathies (9.5%) and renal hypoplasia/dysplasia (10%). Primary glomerular disease is the second-most common etiology accounting for 25% of new cases, predominantly due to focal segmental glomerulosclerosis (FSGS). Secondary glomerulonephritis and vasculitis account for 12% of new cases, of which lupus nephritis is the most common. The underlying etiology of ESRD also varies by age of presentation. As expected, congenital/hereditary/cystic disorders are the most common underlying cause of ESRD amongst the youngest age groups, while primary and secondary glomerular diseases are the leading cause among adolescents.</h4>
<h4 dir="ltr">Kidney transplantation is the preferred treatment for ESRD in children and confers improved survival, skeletal growth, heath-related quality of life, and neuropsychological development compared to dialysis.</h4>
<h4 dir="ltr">Transplantation is initially considered when renal replacement therapy is imminent. Due to increased risk of graft loss and mortality in very young children, most pediatric centers perform kidney transplantation once children achieve a weight above 10–15 kg, which is typically around the age of 2 years. The underlying etiology for kidney failure, the rapidity of decline in kidney function, and the age and size of the patient determine whether an individual can receive a pre-emptive kidney transplant without preceding dialysis, which may provide a graft survival advantage. On average, 30% of pediatric kidney transplant recipients in the U.S. receive pre-emptive transplant, and an additional 24% receive dialysis treatment for less than 1 year prior to transplant.</h4>
<p>The post <a rel="nofollow" href="https://ayhcare.com/outcome-of-pediatric-renal-transplantation/">Outcome of pediatric renal transplantation</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">3205</post-id>	</item>
		<item>
		<title>Kidney transplantation in children</title>
		<link>https://ayhcare.com/posterior-urethral-valves/</link>
		
		<dc:creator><![CDATA[Adminayh]]></dc:creator>
		<pubDate>Sun, 23 Jul 2023 07:09:58 +0000</pubDate>
				<category><![CDATA[دسته‌بندی نشده]]></category>
		<category><![CDATA[affected]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[complications]]></category>
		<category><![CDATA[kidney]]></category>
		<category><![CDATA[posterior]]></category>
		<category><![CDATA[PUV]]></category>
		<category><![CDATA[survival]]></category>
		<category><![CDATA[transplantation]]></category>
		<category><![CDATA[urethral]]></category>
		<category><![CDATA[urological]]></category>
		<guid isPermaLink="false">https://ayhcare.com/?p=3197</guid>

					<description><![CDATA[<p>Let&#8217;s see and hear Dr. Rahimzadeh&#8217;s (Specialist in Pediatric Nephrology) explanation about kidney transplant in children  </p>
<p>The post <a rel="nofollow" href="https://ayhcare.com/posterior-urethral-valves/">Kidney transplantation in children</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></description>
										<content:encoded><![CDATA[<h5>Let&#8217;s see and hear Dr. Rahimzadeh&#8217;s (Specialist in Pediatric Nephrology) explanation about kidney transplant in children</h5>
<div> </div>
<div id="18922508986"><script type="text/JavaScript" src="https://www.aparat.com/embed/p9fjt?data[rnddiv]=18922508986&#038;data[responsive]=yes"></script></div>
<p>The post <a rel="nofollow" href="https://ayhcare.com/posterior-urethral-valves/">Kidney transplantation in children</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">3197</post-id>	</item>
		<item>
		<title>Auditory Training</title>
		<link>https://ayhcare.com/auditory-training/</link>
		
		<dc:creator><![CDATA[Adminayh]]></dc:creator>
		<pubDate>Wed, 14 Dec 2022 13:52:36 +0000</pubDate>
				<guid isPermaLink="false">https://ayhcare.com/?p=3308</guid>

					<description><![CDATA[<p>According to the official announcement of the World Health Organization, one to two out of every 1,000 newborns have hearing loss in one or both ears. According to experts, the maximum time to diagnose hearing problems in babies is up to the age of one month, and finally, the baby should be ready to start [...]</p>
<p>The post <a rel="nofollow" href="https://ayhcare.com/auditory-training/">Auditory Training</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p dir="ltr" style="text-align: left;"><img loading="lazy" decoding="async" class=" wp-image-3310 aligncenter" src="https://ayhcare.com/wp-content/uploads/2022/12/62fd20547bd720e6db9fac23_APD-300x200.png" alt="" width="554" height="369" srcset="https://ayhcare.com/wp-content/uploads/2022/12/62fd20547bd720e6db9fac23_APD-300x200.png 300w, https://ayhcare.com/wp-content/uploads/2022/12/62fd20547bd720e6db9fac23_APD-768x512.png 768w, https://ayhcare.com/wp-content/uploads/2022/12/62fd20547bd720e6db9fac23_APD.png 1000w" sizes="(max-width: 554px) 100vw, 554px" /></p>
<p dir="ltr" style="text-align: left;">According to the official announcement of the World Health Organization, one to two out of every 1,000 newborns have hearing loss in one or both ears.<br />
According to experts, the maximum time to diagnose hearing problems in babies is up to the age of one month, and finally, the baby should be ready to start hearing rehabilitation training by the age of three months, which shows the importance of timely follow-up and parents&#8217; attention to their child&#8217;s hearing problems.</p>
<p>The post <a rel="nofollow" href="https://ayhcare.com/auditory-training/">Auditory Training</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">3308</post-id>	</item>
		<item>
		<title>Implantable Cornea</title>
		<link>https://ayhcare.com/implantable/</link>
		
		<dc:creator><![CDATA[Adminayh]]></dc:creator>
		<pubDate>Sat, 01 Oct 2022 05:23:28 +0000</pubDate>
				<category><![CDATA[دسته‌بندی نشده]]></category>
		<category><![CDATA[corneal]]></category>
		<category><![CDATA[Iran]]></category>
		<category><![CDATA[Linköping]]></category>
		<category><![CDATA[Linköping University]]></category>
		<category><![CDATA[pig]]></category>
		<category><![CDATA[Sweden]]></category>
		<category><![CDATA[transplant]]></category>
		<category><![CDATA[University]]></category>
		<guid isPermaLink="false">https://ayhcare.com/?p=3280</guid>

					<description><![CDATA[<p>The post <a rel="nofollow" href="https://ayhcare.com/implantable/">Implantable Cornea</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></description>
										<content:encoded><![CDATA[	<div id="text-762033764" class="text">
		
<h1 dir="ltr" style="text-align: center;">The use of Implantable Corneas from Pig Skin to Restore Vision</h1>
<p><img loading="lazy" decoding="async" class="wp-image-3457 aligncenter" src="https://ayhcare.com/wp-content/uploads/2023/07/Untitled-design-21-1-300x158.webp" alt="" width="365" height="192" srcset="https://ayhcare.com/wp-content/uploads/2023/07/Untitled-design-21-1-300x158.webp 300w, https://ayhcare.com/wp-content/uploads/2023/07/Untitled-design-21-1-1024x538.webp 1024w, https://ayhcare.com/wp-content/uploads/2023/07/Untitled-design-21-1-768x403.webp 768w, https://ayhcare.com/wp-content/uploads/2023/07/Untitled-design-21-1.webp 1200w" sizes="(max-width: 365px) 100vw, 365px" /></p>
<h4 dir="ltr" style="text-align: left;">Scientists in Sweden from Linköping University have successfully developed implantable corneas from pig skin for 14 previously blind patients. From sites in Iran and India, a study was performed on 20 patients who got an implant for restoring their corneal thickness and curvature to a normal level. The visual outcome was perfect as a human-donated cornea was used.</h4>
<h4 dir="ltr" style="text-align: left;">An implant rejection was prevented due to an eight-week course of immunosuppressive eye drops used instead of the normal regimen typically used following a human corneal transplant. An eight-week course of immunosuppressive eye drops was enough to prevent implant rejection, much shorter than the regimens typically used following a human corneal transplant.</h4>
<h4 dir="ltr" style="text-align: left;">According to the analytics firm Vision Research Reports, the corneal implants market is around $420 million this year but it is expected to increase to $700 million by 2030. This growth is due to the rising prevalence of corneal diseases and the interest of industries in bioengineered, 3D-printed, and stem cell-derived corneas.</h4>
<h4 dir="ltr" style="text-align: left;">Source: Pharmiweb</h4>
<h4 dir="ltr" style="text-align: left;"> corneal / pig / Sweden / Linköping University  / Iran / Transplant</h4>
		
<style>
#text-762033764 {
  text-align: center;
}
</style>
	</div>
	
<p>The post <a rel="nofollow" href="https://ayhcare.com/implantable/">Implantable Cornea</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">3280</post-id>	</item>
		<item>
		<title>CRF in children</title>
		<link>https://ayhcare.com/crf/</link>
		
		<dc:creator><![CDATA[Adminayh]]></dc:creator>
		<pubDate>Sun, 21 Aug 2022 15:22:19 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[approximately]]></category>
		<category><![CDATA[ayhcare]]></category>
		<category><![CDATA[ayhealth]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[chronic renal failure]]></category>
		<category><![CDATA[CRF]]></category>
		<category><![CDATA[different]]></category>
		<category><![CDATA[doctor]]></category>
		<category><![CDATA[Dr]]></category>
		<category><![CDATA[medical]]></category>
		<category><![CDATA[nurse]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[prevalence]]></category>
		<category><![CDATA[renal]]></category>
		<category><![CDATA[society]]></category>
		<category><![CDATA[transplantation]]></category>
		<category><![CDATA[worldwide]]></category>
		<guid isPermaLink="false">https://ayhcare.com/?p=3255</guid>

					<description><![CDATA[<p>CRF in children THE INCIDENCE of chronic renal failure (CRF) in children is unknown, but current data suggest that 1.5 to 3 children per million develop end-stage renal disease (ESRD) each year. The prevalence of CRF in the pediatric population worldwide is approximately 18 per million. It has been reported that approximately 8% of adults [...]</p>
<p>The post <a rel="nofollow" href="https://ayhcare.com/crf/">CRF in children</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></description>
										<content:encoded><![CDATA[<h1 style="text-align: center;"><strong>CRF in children</strong></h1>
<p><img loading="lazy" decoding="async" class="wp-image-3258 aligncenter" src="https://ayhcare.com/wp-content/uploads/2022/08/shutterstock_1417298627-300x249.jpg" alt="" width="320" height="266" srcset="https://ayhcare.com/wp-content/uploads/2022/08/shutterstock_1417298627-300x249.jpg 300w, https://ayhcare.com/wp-content/uploads/2022/08/shutterstock_1417298627.jpg 695w" sizes="(max-width: 320px) 100vw, 320px" /></p>
<p dir="ltr">THE INCIDENCE of chronic renal failure (CRF) in children is unknown, but current data suggest that 1.5<br />
to 3 children per million develop end-stage renal disease (ESRD) each year.</p>
<p dir="ltr">The prevalence of CRF in the pediatric population worldwide is approximately 18 per million.</p>
<p dir="ltr">It has been reported that approximately 8% of adults on dialysis and 20% to 30% of children on dialysis have<br />
abnormal urinary tracts.1 The registry of the North America Pediatric Renal Transplantation society confirms that different forms of obstructive uropathy (including reflux and dysplasia)</p>
<p dir="ltr">were not significantly different with regard to mean donor and recipient ages, and sex distribution. We also divided our patients<br />
into two groups (before versus after 1996,) seeking to match patients by immunosuppressive drugs and year of transplantation.</p>
<p dir="ltr">
Rejection was clinically diagnosed when a patient exhibitedtenderness over the graft site, swelling of the graft on ultrasonography, persistent fever, oliguria, hypertension, and progressive elevation of serum creati nine.</p>
<p dir="ltr">Biopsy was performed in cases of suspected rejection; the diagnosis was confirmed by increased<br />
mesengial matrix, increased lobularity, decreased glomerular size and hyalinization, and vascular and tubular lesions. Children<br />
returned to chronic dialysis, those who required retransplantation, and those who died of renal complications were all considered to have lost their grafts.</p>
<p>&nbsp;</p>
<p>The post <a rel="nofollow" href="https://ayhcare.com/crf/">CRF in children</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">3255</post-id>	</item>
		<item>
		<title>The renal transplant</title>
		<link>https://ayhcare.com/renal/</link>
		
		<dc:creator><![CDATA[Adminayh]]></dc:creator>
		<pubDate>Sun, 14 Aug 2022 13:20:34 +0000</pubDate>
				<category><![CDATA[Asian]]></category>
		<category><![CDATA[best-doctor-in-iran]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Mildiplastic syndrome]]></category>
		<category><![CDATA[renal transplant]]></category>
		<category><![CDATA[transplants]]></category>
		<category><![CDATA[vast]]></category>
		<guid isPermaLink="false">https://ayhcare.com/?p=3251</guid>

					<description><![CDATA[<p>Iran is a vast country in the Middle East. The renal transplant program in Iran is one of the successful programs in the region. In 1988, a controlled live unrelated renal transplant program was started in Iran because of a low numbers of live related donors and because cadaveric renal transplant program was not established [...]</p>
<p>The post <a rel="nofollow" href="https://ayhcare.com/renal/">The renal transplant</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></description>
										<content:encoded><![CDATA[<h1 dir="ltr" style="text-align: center;"><a href="https://ayhcare.com/">Iran</a> is a vast country in the Middle East.</h1>
<p><img loading="lazy" decoding="async" class="wp-image-3252 aligncenter" src="https://ayhcare.com/wp-content/uploads/2022/08/Renal-Transplantation-Surgery-300x157.png" alt="" width="581" height="304" srcset="https://ayhcare.com/wp-content/uploads/2022/08/Renal-Transplantation-Surgery-300x157.png 300w, https://ayhcare.com/wp-content/uploads/2022/08/Renal-Transplantation-Surgery-1024x536.png 1024w, https://ayhcare.com/wp-content/uploads/2022/08/Renal-Transplantation-Surgery-768x402.png 768w, https://ayhcare.com/wp-content/uploads/2022/08/Renal-Transplantation-Surgery.png 1200w" sizes="(max-width: 581px) 100vw, 581px" /></p>
<p dir="ltr" style="text-align: left;">The <a href="https://ayhcare.com/posterior-urethral-valves/">renal transplant</a> program in Iran is one of the successful programs in the region. In 1988, a controlled live unrelated renal transplant program was started in Iran because of a low numbers of live related donors and because cadaveric renal transplant program was not established completely at that time.</p>
<p dir="ltr" style="text-align: left;">Finally, therenal transplant waiting list of the country was eliminated by the end of 1999.</p>
<p dir="ltr" style="text-align: left;">Recently, in the annual report of NAPRTCS, 48.6% of all transplants were from deceased donor, 41.2% were from a parent, with the remaining 10.2% from other living donors.</p>
<p dir="ltr" style="text-align: left;">In developing countries, the donor sources vary depending on cultural and ethical status.</p>
<p dir="ltr" style="text-align: left;">In some countries, most transplants are from living related donors, such as Egypt and some Asian countries.</p>
<p dir="ltr" style="text-align: left;">In contrast, in some other countries, the majority of transplants are from deceased donors such as South Africa, Thailand&#8230;</p>
<p dir="ltr" style="text-align: center;"> </p>
<p>The post <a rel="nofollow" href="https://ayhcare.com/renal/">The renal transplant</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">3251</post-id>	</item>
		<item>
		<title>neutrophil</title>
		<link>https://ayhcare.com/neutrophil-gelatinase/</link>
		
		<dc:creator><![CDATA[Adminayh]]></dc:creator>
		<pubDate>Tue, 19 Jul 2022 17:24:34 +0000</pubDate>
				<category><![CDATA[associated]]></category>
		<category><![CDATA[gelatinase]]></category>
		<category><![CDATA[ipocalin]]></category>
		<category><![CDATA[kidney transplant]]></category>
		<category><![CDATA[neutrophil]]></category>
		<category><![CDATA[NGAL]]></category>
		<category><![CDATA[predict]]></category>
		<category><![CDATA[urine]]></category>
		<guid isPermaLink="false">https://ayhcare.com/?p=3183</guid>

					<description><![CDATA[<p>Does serum and urine neutrophil gelatinase-associated lipocalin ?predict kidney transplant performance in the short term n Abstract: NGAL is a member of the lipocalin protein family that has diverse function but similar structure. The functions of NGAL are not clear, but it appears to be expressed in stress conditions and in tissues undergoing involution. Varied [...]</p>
<p>The post <a rel="nofollow" href="https://ayhcare.com/neutrophil-gelatinase/">neutrophil</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></description>
										<content:encoded><![CDATA[<ul>
<li style="text-align: left;">
<h1 style="text-align: center;">Does serum and urine neutrophil gelatinase-associated lipocalin</h1>
<h1 style="text-align: center;">?predict kidney transplant performance in the short term</h1>
</li>
</ul>
<p>n<img loading="lazy" decoding="async" class=" wp-image-3184 aligncenter" src="https://ayhcare.com/wp-content/uploads/2022/07/csm_Neutrophil_Granularity_1500x600_d606045eef-300x120.jpg" alt="" width="603" height="241" srcset="https://ayhcare.com/wp-content/uploads/2022/07/csm_Neutrophil_Granularity_1500x600_d606045eef-300x120.jpg 300w, https://ayhcare.com/wp-content/uploads/2022/07/csm_Neutrophil_Granularity_1500x600_d606045eef-768x307.jpg 768w, https://ayhcare.com/wp-content/uploads/2022/07/csm_Neutrophil_Granularity_1500x600_d606045eef.jpg 960w" sizes="(max-width: 603px) 100vw, 603px" /></p>
<p style="text-align: left;">
<p style="text-align: left;">Abstract: NGAL is a member of the lipocalin protein family that has diverse function but similar structure. The functions of NGAL are not clear, but it appears to be expressed in stress conditions and in tissues undergoing involution.</p>
<p style="text-align: left;">Varied studies have shown increased levels of plasma or urinary NGAL in diverse renal damages. The aim of this study was the serial measurement of serum and urinary NGAL within the ﬁrst week after renal transplantation in children to predict imme- diate and short-term graft function. A total of 27 patients were assessed.</p>
<p style="text-align: left;">These patients were classiﬁed into those with rapid reduction in serum creatinine (more than 50% reduction in serum creatinine in the ﬁrst day after transplantation) and patients with slow reduction in serum cre- atinine (&lt;50% reduction in serum creatinine). We also assessed the absolute reduction in serum creatinine before and after transplantation. Serum and urinary NGAL on the ﬁrst day post-transplantation were higher in recipients with slow reduction in serum creatinine (urinary NGAL at the ﬁrst day: 197 ± 153 [s.e.m.] vs. 22.54 ± 8.5 [s.e.m.],</p>
<p style="text-align: left;">p = 0.04; serum NGAL at the ﬁrst day: 199 vs. 69.8, p = 0.003). The cutoﬀ point of serum NGAL at the ﬁrst day after transplantation for prediction of slow creatinine reduction was 174 ng/mL with a sensitivity of 100% and speciﬁcity of 95.5%. However, we did not ﬁnd association between the absolute reduction in serum creatinine before and after transplantation with the amount of serum and urinary NGAL post- transplant. Additionally, we did not ﬁnd any eﬀect of high serum and urine NGAL concentration on the graft function at the ﬁrst year post- transplant. Although it is supposed that high serum and urine NGAL may predict ischemia of graft in early phases; however, it appears that this mild ischemic injury to graft without DGF or SGF cannot aﬀect the graft function in short-term period. Further studies are needed using larger transplant recipients in pediatric age group. It is also needed to determine the eﬀects of mild ischemic injuries on the graft function in long-term period in future studies.</p>
<p style="text-align: left;">
<p>The post <a rel="nofollow" href="https://ayhcare.com/neutrophil-gelatinase/">neutrophil</a> appeared first on <a rel="nofollow" href="https://ayhcare.com"> Ay Health Medical Services Company</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">3183</post-id>	</item>
	</channel>
</rss>
